HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

Autor: Dugel, Pravin U., Koh, Adrian, Ogura, Yuichiro, Jaffe, Glenn J., Schmidt-Erfurth, Ursula, Brown, David M., Gomes, Andre V., Warburton, James, Weichselberger, Andreas, Holz, Frank G.
Zdroj: In Ophthalmology January 2020 127(1):72-84
Databáze: ScienceDirect